Table: begin end state 1 27 cytoplasmic 28 49 transmembrane 50 55 non-cytoplasmic 56 79 transmembrane 80 97 cytoplasmic 98 127 transmembrane 128 158 non-cytoplasmic 159 178 transmembrane 179 184 cytoplasmic 185 208 transmembrane 209 233 non-cytoplasmic 234 255 transmembrane 256 266 cytoplasmic 267 295 transmembrane 296 314 non-cytoplasmic 315 341 transmembrane 342 362 cytoplasmic 363 382 transmembrane 383 388 non-cytoplasmic 389 410 transmembrane 411 421 cytoplasmic 422 442 transmembrane 443 447 non-cytoplasmic 448 466 transmembrane 467 475 cytoplasmic
Input: >WP_057509036.1 NCBI__GCF_001431535.1:WP_057509036.1 MSLLRRKSLDTVTVHEAGRQLVRTLSWPHLIALGIGAIVGTGIYTLIGVGANLAGPAVLI SFAIAGAVCACAALSYAELATMMPASGSAYTYSYTALGEIFAWVVGWSLILEYSLVVSTV AVGWSGYFVGFLEWVNSQMGIDIRLPLALSAGPHVEGGVFNLPAVLITWLVAGGLMLGTK ESATLNAVLVVLKLIALGVFIAVALPAFDSANLQPFMPYGFAKSLGPDGLERGVMAAAAI IFFAFYGFDAIATAAEETKNPGRDLSIGIIGSMVGCTIVYMLVALAAVGAMSYAVFGSSA EPLALIMRQLGHPTAALIIGVVAIVALPTVLLAFMFGQSRVFFVMGRDGMLPRRLSNVSK RTGTPVATTLFSALLVSALAGVARLDEIAALANAGTLAAFTAVGVCLVVMRRREPDRART FRTPLAWIVGPAAALGCVYLFFSLPHSTQLYFLIWNVIGLAVYFLYSRRNAVLGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server